Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 7, 2023
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
Luca Issi Reiterated (BMRN) at Hold and Held Target at $100 on, Nov 7th, 2023
Luca Issi of RBC Capital, Reiterated "BioMarin Pharmaceutical Inc." (BMRN) at Hold and Held Target at $100 on, Nov 7th, 2023.
Luca has made no other calls on BMRN in the last 4 months.
There are 14 other peers that have a rating on BMRN. Out of the 14 peers that are also analyzing BMRN, 4 agree with Luca's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- William Pickering of "Bernstein" Upgraded from Sell to Hold and Held Target at $82 on, Monday, October 23rd, 2023
- Laura Chico of "Raymond James" Initiated at Hold on, Thursday, September 28th, 2023
- Andreas Argyrides of "Wedbush" Maintained at Hold with Decreased Target to $70 on, Tuesday, August 1st, 2023
- George Farmer of "Scotiabank" Initiated at Hold and Held Target at $95 on, Thursday, July 27th, 2023
These are the ratings of the 10 analyists that currently disagree with Luca
- Kostas Biliouris of "BMO Capital" Maintained at Buy with Decreased Target to $100 on, Friday, November 3rd, 2023
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $115 on, Thursday, November 2nd, 2023
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $111 on, Thursday, November 2nd, 2023
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $117 on, Thursday, November 2nd, 2023
- Olivia Brayer of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $100 on, Thursday, November 2nd, 2023
- Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $140 on, Monday, September 25th, 2023
- Martin Auster of "UBS" Initiated at Strong Buy and Held Target at $120 on, Monday, September 18th, 2023
- Debjit Chattopadhyay of "Guggenheim" Reiterated at Strong Buy and Held Target at $110 on, Wednesday, September 13th, 2023
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $108 on, Tuesday, August 1st, 2023
- Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $185 on, Friday, July 21st, 2023
